These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 20679480)
1. Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling. Molzan M; Schumacher B; Ottmann C; Baljuls A; Polzien L; Weyand M; Thiel P; Rose R; Rose M; Kuhenne P; Kaiser M; Rapp UR; Kuhlmann J; Ottmann C Mol Cell Biol; 2010 Oct; 30(19):4698-711. PubMed ID: 20679480 [TBL] [Abstract][Full Text] [Related]
3. Structural determinants of Ras-Raf interaction analyzed in live cells. Bondeva T; Balla A; Várnai P; Balla T Mol Biol Cell; 2002 Jul; 13(7):2323-33. PubMed ID: 12134072 [TBL] [Abstract][Full Text] [Related]
4. Ras binding opens c-Raf to expose the docking site for mitogen-activated protein kinase kinase. Terai K; Matsuda M EMBO Rep; 2005 Mar; 6(3):251-5. PubMed ID: 15711535 [TBL] [Abstract][Full Text] [Related]
5. 14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity. Light Y; Paterson H; Marais R Mol Cell Biol; 2002 Jul; 22(14):4984-96. PubMed ID: 12077328 [TBL] [Abstract][Full Text] [Related]
6. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway. Tidyman WE; Rauen KA Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751 [TBL] [Abstract][Full Text] [Related]
7. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling. Kiel C; Serrano L Sci Signal; 2009 Jul; 2(81):ra38. PubMed ID: 19638615 [TBL] [Abstract][Full Text] [Related]
8. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367 [TBL] [Abstract][Full Text] [Related]
9. Synergistic binding of the phosphorylated S233- and S259-binding sites of C-RAF to one 14-3-3ζ dimer. Molzan M; Ottmann C J Mol Biol; 2012 Nov; 423(4):486-95. PubMed ID: 22922483 [TBL] [Abstract][Full Text] [Related]
10. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Avruch J; Khokhlatchev A; Kyriakis JM; Luo Z; Tzivion G; Vavvas D; Zhang XF Recent Prog Horm Res; 2001; 56():127-55. PubMed ID: 11237210 [TBL] [Abstract][Full Text] [Related]
11. The C-terminus of Raf-1 acts as a 14-3-3-dependent activation switch. Dhillon AS; Yip YY; Grindlay GJ; Pakay JL; Dangers M; Hillmann M; Clark W; Pitt A; Mischak H; Kolch W Cell Signal; 2009 Nov; 21(11):1645-51. PubMed ID: 19595761 [TBL] [Abstract][Full Text] [Related]
12. Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids. Wiechmann S; Maisonneuve P; Grebbin BM; Hoffmeister M; Kaulich M; Clevers H; Rajalingam K; Kurinov I; Farin HF; Sicheri F; Ernst A J Biol Chem; 2020 Apr; 295(14):4526-4540. PubMed ID: 32086379 [TBL] [Abstract][Full Text] [Related]
13. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Sun H; King AJ; Diaz HB; Marshall MS Curr Biol; 2000 Mar; 10(5):281-4. PubMed ID: 10712905 [TBL] [Abstract][Full Text] [Related]
14. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Ory S; Zhou M; Conrads TP; Veenstra TD; Morrison DK Curr Biol; 2003 Aug; 13(16):1356-64. PubMed ID: 12932319 [TBL] [Abstract][Full Text] [Related]
15. A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation. Yin X; Zafrullah M; Lee H; Haimovitz-Friedman A; Fuks Z; Kolesnick R Cell Physiol Biochem; 2009; 24(3-4):219-30. PubMed ID: 19710537 [TBL] [Abstract][Full Text] [Related]
16. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Hatzivassiliou G; Song K; Yen I; Brandhuber BJ; Anderson DJ; Alvarado R; Ludlam MJ; Stokoe D; Gloor SL; Vigers G; Morales T; Aliagas I; Liu B; Sideris S; Hoeflich KP; Jaiswal BS; Seshagiri S; Koeppen H; Belvin M; Friedman LS; Malek S Nature; 2010 Mar; 464(7287):431-5. PubMed ID: 20130576 [TBL] [Abstract][Full Text] [Related]
17. Activation of RAF-1 through Ras and protein kinase Calpha mediates 1alpha,25(OH)2-vitamin D3 regulation of the mitogen-activated protein kinase pathway in muscle cells. Buitrago CG; Pardo VG; de Boland AR; Boland R J Biol Chem; 2003 Jan; 278(4):2199-205. PubMed ID: 12417593 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel de novo deletion in RAF1 associated with biventricular hypertrophy in Noonan syndrome. Sana ME; Spitaleri A; Spiliotopoulos D; Pezzoli L; Preda L; Musco G; Ferrazzi P; Iascone M Am J Med Genet A; 2014 Aug; 164A(8):2069-73. PubMed ID: 24782337 [TBL] [Abstract][Full Text] [Related]
19. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E). Karreth FA; DeNicola GM; Winter SP; Tuveson DA Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255 [TBL] [Abstract][Full Text] [Related]
20. KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation. Tran TH; Chan AH; Young LC; Bindu L; Neale C; Messing S; Dharmaiah S; Taylor T; Denson JP; Esposito D; Nissley DV; Stephen AG; McCormick F; Simanshu DK Nat Commun; 2021 Feb; 12(1):1176. PubMed ID: 33608534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]